Your browser doesn't support javascript.
loading
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?
Del Re, M; Citi, V; Crucitta, S; Rofi, E; Belcari, F; van Schaik, R H; Danesi, R.
Afiliação
  • Del Re M; Clinical Pharmacology and Pharmacogenetics Unit, Department of Laboratory Medicine, University Hospital, Pisa, Italy. Electronic address: marzia.delre@for.unipi.it.
  • Citi V; Clinical Pharmacology and Pharmacogenetics Unit, Department of Laboratory Medicine, University Hospital, Pisa, Italy.
  • Crucitta S; Clinical Pharmacology and Pharmacogenetics Unit, Department of Laboratory Medicine, University Hospital, Pisa, Italy.
  • Rofi E; Clinical Pharmacology and Pharmacogenetics Unit, Department of Laboratory Medicine, University Hospital, Pisa, Italy.
  • Belcari F; Clinical Pharmacology and Pharmacogenetics Unit, Department of Laboratory Medicine, University Hospital, Pisa, Italy.
  • van Schaik RH; Department of Clinical Chemistry, Erasmus MC, Rotterdam, The Netherlands.
  • Danesi R; Clinical Pharmacology and Pharmacogenetics Unit, Department of Laboratory Medicine, University Hospital, Pisa, Italy.
Pharmacol Res ; 107: 398-406, 2016 05.
Article em En | MEDLINE | ID: mdl-27060675

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Citocromo P-450 CYP2D6 / Antagonistas de Estrogênios Limite: Animals / Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Citocromo P-450 CYP2D6 / Antagonistas de Estrogênios Limite: Animals / Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2016 Tipo de documento: Article